▶ 調査レポート

ヒト個人識別のグローバル市場(2023~2028):ポリメラーゼ連鎖反応(PCR)、次世代シーケンス(NGS)、核酸精製・抽出、キャピラリー電気泳動法、その他

• 英文タイトル:Human Identification Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

Mordor Intelligenceが調査・発行した産業分析レポートです。ヒト個人識別のグローバル市場(2023~2028):ポリメラーゼ連鎖反応(PCR)、次世代シーケンス(NGS)、核酸精製・抽出、キャピラリー電気泳動法、その他 / Human Identification Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028) / MRC2303K021資料のイメージです。• レポートコード:MRC2303K021
• 出版社/出版日:Mordor Intelligence / 2023年2月
• レポート形態:英文、PDF、120ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:IT
• 販売価格(消費税別)
  Single User¥712,500 (USD4,750)▷ お問い合わせ
  Corporate License¥1,312,500 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社の調査レポートでは、年度末に1,393.25百万ドルであった世界のヒト個人識別市場規模が、予測期間中、CAGR 11.85%で増大すると予測されています。本レポートでは、ヒト個人識別の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、技術別(ポリメラーゼ連鎖反応(PCR)、次世代シーケンス(NGS)、核酸精製・抽出、キャピラリー電気泳動法、その他)分析、製品・サービス別(器具、アッセイキット・試薬、ソフトウェア・サービス)分析、用途別(法医学応用、実父確定検査、その他)分析、地域別(アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン)分析、競争状況、市場機会・将来動向などについて調査・分析などの項目を掲載しています。並び、こちらのレポートには、Abbott Laboratories、Agilent Technologies,Inc.、GE Healthcare、Thermo Fisher Scientific Inc.、Autogen Inc.、Illumina Inc.、Eurofins Scientific、Laboratory Corporation of America Holdings、Hamilton Company、Qiagen N.V.などの企業情報が含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界のヒト個人識別市場規模:技術別
- ポリメラーゼ連鎖反応(PCR)における市場規模
- 次世代シーケンス(NGS)における市場規模
- 核酸精製・抽出における市場規模
- キャピラリー電気泳動法における市場規模
- その他技術における市場規模
・世界のヒト個人識別市場規模:製品・サービス別
- 器具の市場規模
- アッセイキット・試薬の市場規模
- ソフトウェア・サービスの市場規模
・世界のヒト個人識別市場規模:用途別
- 法医学応用における市場規模
- 実父確定検査における市場規模
- その他用途における市場規模
・世界のヒト個人識別市場規模:地域別
- 北米のヒト個人識別市場規模
アメリカのヒト個人識別市場規模
カナダのヒト個人識別市場規模
メキシコのヒト個人識別市場規模

- ヨーロッパのヒト個人識別市場規模
ドイツのヒト個人識別市場規模
イギリスのヒト個人識別市場規模
フランスのヒト個人識別市場規模

- アジア太平洋のヒト個人識別市場規模
中国のヒト個人識別市場規模
日本のヒト個人識別市場規模
インドのヒト個人識別市場規模

- 南米/中東のヒト個人識別市場規模
南アフリカのヒト個人識別市場規模
ブラジルのヒト個人識別市場規模
アルゼンチンのヒト個人識別市場規模

・競争状況
・市場機会・将来動向

The human identification market is currently valued at USD 1,393.25 million and is expected to register a CAGR of 11.85% over the forecast period.

The COVID-19 pandemic had a significant impact on the human identification market as many human identification services were hampered during the peak of COVID-19, especially forensic activities. For instance, according to the study published in the Journal of Safety Science and Resilience in February 2022, crime, and illicit economies, such as organized crime, domestic violence, terrorism, street crime, online crime, illegal markets and smuggling, human and wildlife trafficking, slavery, robberies, and burglaries decreased exponentially during the pandemic era. Thus, a decrease in crimes and investigations during the pandemic reduced the number of forensic tests, impeding the market’s growth. Moreover, COVID-19 led to some revolutionary developments in the polymerase chain reaction technology and as the infection rate decreased significantly along with large-scale vaccination, the studied market was expected to recover from the COVID-19 effect and have healthy growth over the forecast period.

The market is driven by an increase in technological advancement in human identification technology, and various government initiatives and supports. There is the rapid growth of technological advancements in human identification that is highly important to make the world more secure and these techniques are extensively used in forensics for the identification of criminals. There are new techniques and technologies for DNA profiling continue to evolve every year. In May 2022, Promega’s Spectrum CE System introduced a new alternative in a market capillary electrophoresis (CE) instrument. The instrument provides forensic analysts with unrivalled flexibility in how they process samples using short tandem repeat (STR) analysis by eliminating scheduling challenges and supporting chemistry from key vendors. Human identification in criminal casework and database cases now has a new option for capillary electrophoresis (CE) instruments to support their workflow.

Additionally, governments around the world have increased their support for the field due to the potential and rising demand for human identification in various industries. For instance, in March 2022, Mexican President Andrés Manuel López Obrador (AMLO) approved the formation of a National Center for Human Identification.

Furthermore, the strategic initiatives such as collaborations and product launches undertaken by the market players contribute to the market growth. For instance, in June 2021, QIAGEN N.V. reported a commercialization partnership with San Diego-based human identification specialist Verogenthat will provide customers of both companies with superior tools and comprehensive support for human identification (HID) workflows in their laboratories. Further, in March 2022, Mexican President Andres Manuel Lopez Obrador (AMLO) approved the formation of a National Center for Human Identification. In March 2022, ARUP Laboratories launched a new bioinformatics platform for better, faster next-generation sequencing test results, Rio, an advanced bioinformatics pipeline and analytics platform. Rio extends ARUP’s existing cloud computing capabilities to transfer data more quickly and accurately, allowing clinicians to analyze test findings more quickly and make better medical decisions. Hence, the company’s activities in the human identification segment are expected to boost the studied market growth.

Thus, the studied market growth is attributed to the above mentioned factors, and the market is expected to grow significantly over the forecast period. However, the cost of instruments and the shortage of skilled professionals might hinder market growth.

Human Identification Market Trends

Forensic Applications Segment is Expected to Witness Healthy Growth Over the Forecast Period

Human identification is widely used in forensics, paternity testing, disaster victim identification, and anthropology, with DNA analysis/profiling being a key tool in this sector. The increasing crime rate across the globe is one of the major factors driving the growth of this segment.

In typical forensic services engaged by a genetic engineering company, there are data accumulated from several sources, including serology and DNA analysis, and profiling DNA from various sources, such as tissue samples from autopsy and surgery, scrapings from blood spatter, and hair with roots, among others. The biotechnology-based companies are also engaged in criminal justice-related services. For instance, in March 2022, the Spectrum CE System of Promega corporation was launched. This system is compatible with any 5-, 6- or 8-color STR analysis chemistry for use in forensic laboratories for human identification. Thus, the advances are expected to drive segment growth.

Moreover, In October 2021, the Indian Government launched three fast-track DNA testing units in Mumbai, Nagpur, and Pune under the Nirbhaya scheme for women and child sexual abuse cases. This growing number of crime and government initiatives globally are expected to drive segment growth.

The demand for identification technology is rising continuously due to the growing rate of crimes is boosting the need for forensic kits and services, enhancing the segment growth over the forecast period.

North America Holds a Significant Share in the Market and Expected to do Same during the Forecast Period

North America holds a significant share of the human identification market. The North American human identification market is expected to grow during the forecast period owing to the technological advancements in the human identification system coupled with the increasing demand for reducing the time and cost of DNA analysis and growing use in forensics in this country.

The funding from the United States government for supporting forensics is rising, which is responsible for the growth of the region. For instance, in 2021, the Department of Justice’s Office of Justice Programs (OJP) granted awards totalling more than USD 210 million to fund crime laboratories, support research, decrease DNA backlogs, and help law enforcement identify missing persons. Further, the increasing adoption of human identification system techniques by government offices in the United States for forensic purposes is also expected to propel the market’s growth. Such as, in August 2020, the New York City medical examiner’s office approved to use next-generation sequencing, which the Department of Défense is already using to identify remains from World War II and the Korean and Vietnam Wars. Thus, the adoption of products and services by government offices and funding for the development of human identification services is bolstering the market growth in the country.

Moreover, the recent development in the countries across North America is the major factor driving the studied market growth. For example, in February 2021, ANDE corporation launched the Rapid DNA booking management product suite, which is available for immediate delivery. Moreover, in March 2022, Ancestry DNA company was launched in Mexico as a geographical expansion strategy. This launch provides customers in Mexico access to the world’s largest consumer DNA match network, which includes over 1.5 million of Mexican descent and the full ancestry DNA feature set, including ethnicity estimates and other access. Thus, the recent advances in the countries across the region are driving market growth.

Therefore, owing to the previously mentioned factors, the growth of the studied market is predicted in the North American region.

Human Identification Market Competitor Analysis

The human identification market is moderately competitive. There has been a presence of a considerable number of companies that are significantly contributing to the market growth. Product innovation and ongoing development activities for developing advanced technologies have been helping the growth of the market. Key market players operating in the global human identification market include Promega Corporation, AUTOGEN INC, Thermo Fisher Scientific Inc., Verogen Inc., Laboratory Corporation of America Holdings, Hamilton Company, Qiagen NV, ANDE Corporation, GENETEK Biopharma GmbH, and Bio-Rad Laboratories, Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Drivers
4.1.1 Technological Advancements in Human Identification System
4.1.2 Increasing Demand for Reducing the Time and Cost of DNA Analysis
4.1.3 Government Initiatives and Support
4.2 Market Restraints
4.2.1 Expensive Instruments
4.2.2 Shortage of Skilled Professionals
4.3 Porter’s Five Forces Analysis
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Technology
5.1.1 Polymerase Chain Reaction (PCR)
5.1.2 Next Generation Sequencing (NGS)
5.1.3 Nucleic Acid Purification and Extraction
5.1.4 Capillary Electrophoresis
5.1.5 Rapid DNA Analysis
5.1.6 Other Technologies
5.2 By Product & Service
5.2.1 Instruments
5.2.2 Assay Kits and Reagents
5.2.3 Software and Services
5.3 By Application
5.3.1 Forensic Applications
5.3.2 Paternity Testing
5.3.3 Other Applications
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Agilent Technologies,Inc.
6.1.3 GE Healthcare
6.1.4 Thermo Fisher Scientific Inc.
6.1.5 Autogen Inc.
6.1.6 Illumina Inc.
6.1.7 Eurofins Scientific
6.1.8 Laboratory Corporation of America Holdings
6.1.9 Hamilton Company
6.1.10 Qiagen N.V.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS